Arun Purohit
Dr Arun Purohit, MD (General Medicine) is a pharmaceutical and healthcare consultant with various companies including Medicines Patent Pool, Geneva, a nonprofit organization in public health patent access for generic companies. He has held leadership positions during a tenure of 30 years in reputed pharma companies like Cadila Pharma and Ranbaxy Labs (now Sun Pharma), where he excelled in medico-marketing, product portfolio management, CMEs and training. Arun has been on the advisory board of some Journals in India and is currently a reviewer on the Editorial Board of ‘The Journal of Generic Medicines’ published from UK. He is a life member of the Association of Physicians of India and Indian Pharmacology Society.
Disclaimer
Copyright 2025 by Soterius, Inc. All rights reserved. Soterius logo are trademarks or registered trademarks of Soterius in all jurisdictions. Other marks may be trademarks or registered trademarks of their respective owners. The information you see, hear or read on the pages within this presentation, as well as the presentation’s form and substance, are subject to copyright protection. In no event, may you use, distribute, copy, reproduce, modify, distort, or transmit the information or any of its elements, such as text, images or concepts, without the prior written permission of Soterius. No license or right pertaining to any of these trademarks shall be granted without the written permission of Soterius (and any of its global offices and/or affiliates). Soterius reserves the right to legally enforce any infringement of its intellectual property, copyright and trademark rights.
Any content presented herewith should only be considered for general informational purposes and should not be considered as specific to the requirements of any particular organisation or for any specific purpose. Soterius does not make any representations or warranties about the completeness, reliability, appropriateness, relevance, or accuracy of the content presented here.
Discover more
admin •
10 Min Read
Deploying an Inspection Ready AI System in PV
Artificial intelligence in pharmacovigilance should not be assessed by how advanced the technology is. It should be assessed by what happens when the technology is wrong. Executive Summary Artificial intelligence…
admin •
10 Min Read
Is it Drug Induced Liver Injury (DILI), or something else?
Ever faced a hepatic signal in a trial that looked like classic drug-induced liver injury (DILI), but turned out to be something entirely different? Here’s a hypothetical scenario that might…
admin •
10 Min Read
Medication Errors & Patient Safety – Part I
Why Medication Errors Matter More Than We Think Medication errors are a significant public health concern, often occurring during various stages of care, whether preventive, diagnostic, therapeutic, or rehabilitative. These…